4.8 Article

LIN28B Promotes Colon Cancer Progression and Metastasis

Journal

CANCER RESEARCH
Volume 71, Issue 12, Pages 4260-4268

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-10-4637

Keywords

-

Categories

Funding

  1. Hansen Foundation
  2. National Colon Cancer Research Alliance (EIF)
  3. Ministerio de Ciencia e Innovacion [SAF2010-19273]
  4. Asociacion Espanola contra el Cancer (Fundacion Cientifica y Junta de Barcelona)
  5. Agencia de Gestio d'Ajuts Universitaris i de Recerca [SGR 849]
  6. Pfizer
  7. [R01-DK056645]

Ask authors/readers for more resources

LIN28B is a homologue of LIN28 that induces pluripotency when expressed in conjunction with OCT4, SOX2, and KLF4 in somatic fibroblasts. LIN28B represses biogenesis of let-7 microRNAs and is implicated in both development and tumorigenesis. Recently, we have determined that LIN28B overexpression occurs in colon tumors. We conducted a comprehensive analysis of LIN28B protein expression in human colon adenocarcinomas. We found that LIN28B overexpression correlates with reduced patient survival and increased probability of tumor recurrence. To elucidate tumorigenic functions of LIN28B, we constitutively expressed LIN28B in colon cancer cells and evaluated tumor formation in vivo. Tumors with constitutive LIN28B expression exhibit increased expression of colonic stem cell markers LGR5 and PROM1, mucinous differentiation, and metastasis. Together, our findings point to a function for LIN28B in promoting colon tumor pathogenesis, especially metastasis. Cancer Res; 71(12); 4260-8. (C)2011 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available